Key Market Indicators
Sales of blood and blood forming organs medicines in Ireland are expected to reach $157.8 million by 2026, a 0.9% increase from 2021's $149.2 million. Since 2013, Irish demand has grown 5.1% on average each year. Ireland ranked 22nd in 2021, with Chile taking the lead at $149.2 million. Germany, Italy, and South Korea followed in second, third, and fourth place, respectively. The prevalence of anemia in Ireland is projected to reach 6,610 hospital discharges by 2026, a 2.1% increase from 5,780 hospital discharges in 2021. Since 2000, Irish demand has grown 5% each year on average. In 2021, Ireland ranked 21st, with Finland coming in first at 5,780 hospital discharges. Germany, the United Kingdom, and Poland followed in second, third, and fourth place, respectively.
